Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the ...

The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

A new review of research on 64 herbal remedies and dietary supplements for depression found ‘substantive’ evidence that only ...

Just days after the Senate confirmed a new head of the Drug Enforcement Administration (DEA), the agency is promoting yet another message warning against marijuana use, linking it to depression and ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in pregnancy.

Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...